Peripheral blood circular RNA markers and applications for non-invasive diagnosis of active pulmonary tuberculosis
A technology of active pulmonary tuberculosis and markers, applied in the direction of DNA/RNA fragments, recombinant DNA technology, biochemical equipment and methods, etc., can solve the problems that affect the sensitivity and clinical applicability of detection methods, difficult detection, and limit clinical transformation process, etc. problem, to achieve the effect of being suitable for popularization, high accuracy and good stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Example 1: Screening of active pulmonary tuberculosis diagnostic markers
[0034] In order to screen the diagnostic markers for active pulmonary tuberculosis, the present invention first analyzes the expression data of circRNA in PBMCs of a population used to discover the diagnostic markers for active pulmonary tuberculosis. As shown in Table 1, the population used to discover diagnostic markers included two active tuberculosis patients and two healthy controls matched in age and sex with active tuberculosis patients, including a group of young male paired case-controls and a group of A paired case-control case in older women.
[0035] Table 1
[0036]
[0037] The differences in the expression levels of PBMC circRNA in the paired case-control groups above were analyzed. Such as figure 1 As shown, the analysis results showed that the proportion of circRNA transcripts in the PBMC transcriptome of the two tuberculosis patients was increased.
[0038] Such as figu...
Embodiment 2
[0047] Example 2: Verification and application of "7-circRNA markers" in independent sample sets
[0048] In order to verify the effectiveness of "7-circRNA markers" in the diagnosis of active pulmonary tuberculosis, the expression data of the above 7 circRNAs in PBMCs of another verification population were obtained. This group was completely independent from the group used for marker discovery, including 11 healthy controls and 10 active tuberculosis patients, and there was no significant difference in age and gender between cases and controls (Table 4).
[0049] Table 4
[0050]
[0051] The sequence information of seven circRNAs was obtained from the circBase database, and specific back-to-back primers for amplifying each circRNA were designed according to the specific sequences on the circRNAs to distinguish linear RNAs. Expression levels of seven circRNAs in individual PBMCs. Among them, the forward primer and reverse primer of hsa_circ_0000681 are respectively show...
Embodiment 3
[0078] Example 3: Active tuberculosis diagnostic kit based on "7-circRNA marker"
[0079] Based on the "7-circRNA marker" screened and validated for the diagnosis of active pulmonary tuberculosis by the present invention, a diagnostic kit containing all the specific back-to-back primers for 7 circRNAs was further developed to obtain the expression levels of 7 circRNAs in human PBMC Determination and diagnosis of tuberculosis.
[0080] The production and operation process of the non-invasive diagnostic kit for active pulmonary tuberculosis is based on cell separation, RNA extraction, qRT-PCR and other technologies. The specific methods include: PBMC isolation; PBMC RNA extraction; "7-circRNA marker" detection and risk value calculation Wait.
[0081] The kit includes 7 circRNA-specific back-to-back primers;
[0082] Commonly used reagents for separating human PBMCs include: incomplete RPMI-1640 medium, human lymphocyte separation medium, etc.;
[0083] Common reagents for ex...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com